Home

SAMUEL R MD NUSSBAUM

CIK 1199310 · EVP & Chief Medical Officer · last filed 2021-06-16

SAMUEL R MD NUSSBAUM is an EVP & Chief Medical Officer who has filed 45 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for PROG, was dated Jun 16, 2021. Across all open-market trades the lifetime net is −$54.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $521.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$521.6K

Companies

6

Total Filings

45

Lifetime Open-Market Net

-$54.57M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIORA THERAPEUTICS, INC. (PROG) Delisted Director 47,518 $0.88 $42.0K $0 1 2021-06-16
Motus GI Holdings, Inc. (MOTS) Delisted Director 258 $0.00 $0 $50.0K 7 2021-02-19
CHRS Director — $1.44 — $0 4 2021-01-13
ANTX EVP & Chief Medical Officer 110,972 $4.70 $521.6K -$1.65M 1 2015-05-21
Elevance Health, Inc. (ANTM) Delisted EVP & Chief Medical Officer 110,972 $482.58 $53.55M -$9.24M 3 2015-05-13
Elevance Health, Inc. (WLP) Delisted EVP & Chief Medical Officer 143,757 — — -$43.73M 29 2014-11-04

Recent Filings

45 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-06-16 BIORA THERAPEUTICS, INC. (PROG) Delisted Grant (A) +29,183 $0 EDGAR
2021-02-19 Motus GI Holdings, Inc. (MOTS) Delisted Grant (A) +50,225 $0 EDGAR
2021-01-14 Motus GI Holdings, Inc. (MOTS) Delisted Grant (A) +8,334 $0 EDGAR
2021-01-13 CHRS Grant (A) — $0 EDGAR
2020-10-13 Motus GI Holdings, Inc. (MOTS) Delisted Grant (A) +9,430 $0 EDGAR
2020-07-13 Motus GI Holdings, Inc. (MOTS) Delisted Grant (A) +7,200 $0 EDGAR
2020-02-07 Motus GI Holdings, Inc. (MOTS) Delisted Grant (A) +12,500 $0 EDGAR
2020-01-14 CHRS Grant (A) — $0 EDGAR
2019-02-15 Motus GI Holdings, Inc. (MOTS) Delisted Grant (A) — $0 EDGAR
2019-01-30 CHRS Grant (A) — $0 EDGAR
Showing 1–10 of 45
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.